Infinium Pharmachem Limited (NSE:INFINIUM)
India
· Delayed Price · Currency is INR 212.00
+4.50 (2.17%)
Apr 29, 2026, 2:39 PM IST
Infinium Pharmachem Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2019 |
| Operating Revenue | 1,568 | 1,557 | 1,357 | 1,142 | 991.19 | 545.58 | Upgrade
|
| Other Revenue | - | - | - | - | - | 2.01 | Upgrade
|
| Revenue | 1,568 | 1,557 | 1,357 | 1,142 | 991.19 | 547.59 | Upgrade
|
| Revenue Growth (YoY) | -0.23% | 14.78% | 18.77% | 15.24% | 81.01% | 50.32% | Upgrade
|
| Cost of Revenue | 1,164 | 1,178 | 1,040 | 810.2 | 769.18 | 397.69 | Upgrade
|
| Gross Profit | 404.22 | 378.89 | 316.45 | 332.05 | 222.01 | 149.9 | Upgrade
|
| Selling, General & Admin | 90.58 | 87.88 | 65.86 | 57.95 | 38.23 | 23.79 | Upgrade
|
| Other Operating Expenses | 128.27 | 125.37 | 65.02 | 113.54 | 82.27 | 74.59 | Upgrade
|
| Operating Expenses | 252.23 | 246.19 | 157.56 | 184.88 | 127.88 | 104.89 | Upgrade
|
| Operating Income | 151.99 | 132.7 | 158.89 | 147.16 | 94.13 | 45.01 | Upgrade
|
| Interest Expense | -24.82 | -24.93 | -18.53 | -27.94 | -14.4 | -9.16 | Upgrade
|
| Interest & Investment Income | 0.89 | 0.89 | 1.82 | 0.2 | 0.3 | 0.18 | Upgrade
|
| Currency Exchange Gain (Loss) | 9.7 | 9.7 | 6.87 | 9.97 | 2.08 | 3.63 | Upgrade
|
| Other Non Operating Income (Expenses) | -3.46 | -2.65 | 3.06 | 0.15 | 4.21 | -2.08 | Upgrade
|
| EBT Excluding Unusual Items | 134.29 | 115.7 | 152.1 | 129.53 | 86.32 | 37.58 | Upgrade
|
| Pretax Income | 134.29 | 115.7 | 152.1 | 129.53 | 86.32 | 37.58 | Upgrade
|
| Income Tax Expense | 38.95 | 37.27 | 37.07 | 31.36 | 19.47 | 10.39 | Upgrade
|
| Earnings From Continuing Operations | 95.34 | 78.43 | 115.03 | 98.17 | 66.86 | 27.19 | Upgrade
|
| Minority Interest in Earnings | -1.94 | 3.02 | -2.01 | -3.27 | -5.79 | - | Upgrade
|
| Net Income | 93.4 | 81.45 | 113.02 | 94.9 | 61.06 | 27.19 | Upgrade
|
| Net Income to Common | 93.4 | 81.45 | 113.02 | 94.9 | 61.06 | 27.19 | Upgrade
|
| Net Income Growth | -1.67% | -27.93% | 19.10% | 55.41% | 124.55% | 167.10% | Upgrade
|
| Shares Outstanding (Basic) | 15 | 15 | 11 | 10 | 10 | 10 | Upgrade
|
| Shares Outstanding (Diluted) | 15 | 15 | 11 | 10 | 10 | 10 | Upgrade
|
| Shares Change (YoY) | 10.71% | 36.49% | 4.80% | - | - | - | Upgrade
|
| EPS (Basic) | 6.07 | 5.60 | 10.61 | 9.33 | 6.01 | 2.67 | Upgrade
|
| EPS (Diluted) | 6.07 | 5.60 | 10.61 | 9.33 | 6.01 | 2.67 | Upgrade
|
| EPS Growth | -11.18% | -47.21% | 13.64% | 55.41% | 124.55% | 167.23% | Upgrade
|
| Free Cash Flow | -306.29 | -343.76 | 14.06 | 11.23 | 70.69 | 22.11 | Upgrade
|
| Free Cash Flow Per Share | -19.90 | -23.64 | 1.32 | 1.10 | 6.95 | 2.17 | Upgrade
|
| Gross Margin | 25.78% | 24.33% | 23.33% | 29.07% | 22.40% | 27.37% | Upgrade
|
| Operating Margin | 9.69% | 8.52% | 11.71% | 12.88% | 9.50% | 8.22% | Upgrade
|
| Profit Margin | 5.96% | 5.23% | 8.33% | 8.31% | 6.16% | 4.97% | Upgrade
|
| Free Cash Flow Margin | -19.54% | -22.08% | 1.04% | 0.98% | 7.13% | 4.04% | Upgrade
|
| EBITDA | 185.37 | 165.64 | 185.57 | 160.55 | 100.44 | 51.52 | Upgrade
|
| EBITDA Margin | 11.82% | 10.64% | 13.68% | 14.06% | 10.13% | 9.41% | Upgrade
|
| D&A For EBITDA | 33.38 | 32.95 | 26.68 | 13.39 | 6.31 | 6.51 | Upgrade
|
| EBIT | 151.99 | 132.7 | 158.89 | 147.16 | 94.13 | 45.01 | Upgrade
|
| EBIT Margin | 9.69% | 8.52% | 11.71% | 12.88% | 9.50% | 8.22% | Upgrade
|
| Effective Tax Rate | 29.00% | 32.21% | 24.37% | 24.21% | 22.55% | 27.64% | Upgrade
|
| Revenue as Reported | 1,588 | 1,578 | 1,372 | 1,156 | 1,001 | 551.81 | Upgrade
|
| Advertising Expenses | - | 13.59 | 6.75 | 4.24 | 2.83 | 1.68 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.